Medication Safety Governance: Introduction 101
SKS Medication Safety Series, Chapter 1 of 15 · Standard SİY01
Prof. Dr. Mehmet Nurullah Kurutkan, Düzce Üniversitesi İşletme Fakültesi Sağlık Yönetimi Bölümü
Chapter at a glance
Every safe medication process in a hospital rests on someone being responsible for it. This chapter explains what medication safety governance means, who carries it (the medication management team, the pharmacy and therapeutics committee, clinical pharmacists, nurse leaders) and what the evidence says about programmes led by these actors. It corresponds to SKS standard SİY01, which requires a defined medication management team with written responsibilities (Sağlık Bakanlığı, 2020).
Evidence base: 138 records of a 4948-record Web of Science corpus on hospital medication safety (Section 7). Reading time: about 25 minutes. Prior knowledge required: none.
Learning objectives
After working through this chapter, the reader should be able to:
- define medication safety governance and name its main structures;
- explain the responsibilities that SKS SİY01 assigns to the medication management team;
- summarise the evidence on pharmacist-led and hospital-wide medication safety programmes;
- distinguish governance from the individual process steps it oversees;
- identify the main measurement problems in evaluating governance interventions.
Key concepts
- Medication safety governance: the structures, roles and rules through which a hospital oversees its whole medication-use process
- Pharmacy and therapeutics committee (PTC): a multidisciplinary committee that manages the formulary and drug-use policies
- Medication management team (İlaç yönetimi ekibi): the SKS term for the team responsible for medication processes
- Clinical pharmacist: a pharmacist working at ward level on patient-specific therapy
- Medication safety programme: a planned bundle of interventions aimed at reducing medication harm
- Safety organizing: collective behaviours through which units detect and correct errors
Contents: How this chapter was produced · 1. Introduction · 2. History and development · 3. Definitions and conceptual schema · 4. Distinguishing it from neighbouring concepts · 5. Types and classifications · 6. Theoretical frameworks and models · 7. Themes and bibliometric profile · 8. The situation in Türkiye · 9. Debates and contradictions in the literature · 10. Measurement problems · 11. Research gaps and agenda · 12. Implications for practice today · Summary · Discussion questions · Further reading · Glossary · References · Source verification and AI use statement · Data and supplementary material
How this chapter was produced
Box 1. Method
Database: Web of Science Core Collection (SCI-EXPANDED, SSCI, ESCI); English; articles and reviews (including early access). Search date: 16 November 2026; all years (1981 to 2027).
Search: (#1 medication safety and error terms AND #2 hospital settings AND #3 fifteen SKS content blocks) NOT #4 animal and preclinical terms; the full string is on the series hub.
Screening: five export files (4955 records) were merged; 7 duplicates were removed by WoS accession number, DOI and normalised title plus year, leaving 4948 records. Records were assigned to this sub-topic when its term set (therapeutics committee, medication safety officer or committee, clinical pharmacist, pharmacist-led, pharmaceutical care, pharmacist intervention, medication safety programme, governance) appeared in the title or keywords; a record can belong to several sub-topics. Included here: 138 records (73 with the term in the title; 20 reviews).
Limitations: single database; English only; assignment by term matching, checked by reading titles of the most cited and most recent records; claims are checked against abstracts, not full texts.
4955 records
73 title matches; 20 reviews
other chapters or general records
1. Introduction
Imagine a hospital in which every nurse, physician and pharmacist works carefully, yet nobody owns the medication process as a whole. Storage rules differ between wards, high-risk drugs are labelled differently on each floor and error reports pile up without analysis. Individual diligence cannot fix problems that live between departments. Medication safety governance is the answer to this gap: it assigns responsibility for the entire chain, from procurement to disposal.
The Turkish Health Quality Standards (SKS) make this explicit. Standard SİY01 requires a team responsible for medication management, drawn from staff working in medication processes, whose responsibilities cover at least the regulation and audit of all medication processes, the hospital formulary, the principles of rational drug use and an antibiotic use control and prophylaxis guide (Sağlık Bakanlığı, 2020). The literature reviewed here shows why such a structure matters: a hospital-wide programme of low-cost interventions focused on high-risk medications and driven by internal event reporting produced a large and sustained fall in patient harm in a community hospital (Cohen et al., 2005).
2. History and development
The oldest governance records in the corpus are surveys of hospital pharmacy practice by the American Society of Health-System Pharmacists (ASHP), which documented how hospitals organised medication-use oversight in the 1990s (Reeder et al., 1997). In the 2000s the focus moved to evaluated programmes, such as the community-hospital medication safety programme (Cohen et al., 2005), and to the organisational conditions that support safe practice on nursing units (Vogus & Sutcliffe, 2007). Since 2015, governance research has been dominated by pharmacist-led services, above all medication reconciliation at transitions of care, whose effectiveness has been synthesised in systematic reviews (McNab et al., 2018; Mekonnen et al., 2016). The most recent records examine how programmes are implemented and scaled across sites (Kegler et al., 2022; Vandenberg et al., 2020).
- 1997 ASHP national survey describes how acute care hospitals organise pharmacy services (Reeder et al., 1997).
- 2005 A hospital-wide medication safety programme reduces adverse drug events in a community hospital (Cohen et al., 2005).
- 2007 Safety organizing and trusted leadership linked to fewer reported medication errors on nursing units (Vogus & Sutcliffe, 2007).
- 2016 Meta-analysis: pharmacist-led reconciliation programmes reduce post-discharge healthcare use (Mekonnen et al., 2016).
- 2017 Survey of pharmacy and therapeutics committees in South African public hospitals (Matlala et al., 2017).
- 2020 Pharmacist-led transitions-of-care programmes reduce readmissions in large health systems (Layman et al., 2020; Miller et al., 2020).
- 2022 Implementation science frameworks applied to multi-site medication safety programmes (Kegler et al., 2022).
3. Definitions and conceptual schema
| Source | Year | Discipline | Definition (paraphrased) | Emphasised dimension |
|---|---|---|---|---|
| Sağlık Bakanlığı, 2020 | 2020 | Accreditation standard | A team responsible for medication management, with written responsibilities for regulating and auditing all medication processes, the formulary, rational use and antibiotic control. | Accountability structure |
| Cohen et al., 2005 | 2005 | Hospital quality improvement | A planned series of low-cost interventions focused on high-risk medications and informed by internal event reports. | Programme and learning loop |
| Vogus & Sutcliffe, 2007 | 2007 | Organisational behaviour | Safety organizing: collective processes by which unit members detect, discuss and correct errors, strengthened by trusted leadership. | Culture and leadership |
| Matlala et al., 2017 | 2017 | Pharmacy policy | The pharmacy and therapeutics committee as the body that manages the formulary, guidelines and adverse drug reaction reporting. | Committee functions |
| Mekonnen et al., 2016 | 2016 | Clinical pharmacy | Pharmacist-led services that take responsibility for accurate medication lists and therapy review at transitions. | Professional role |
a defined body or role holds accountability for the whole medication-use process and uses information to improve it
Figure 3 shows that the definitions converge on accountability plus information. They diverge on where governance sits: in a formal structure such as the SKS team or the committee (Matlala et al., 2017; Sağlık Bakanlığı, 2020), in a professional role (Mekonnen et al., 2016) or in the culture of the unit (Vogus & Sutcliffe, 2007).
4. Distinguishing it from neighbouring concepts
Governance overlaps most with medication reconciliation and prescribing, because many governance interventions in the corpus are delivered by pharmacists at these steps (Figure 4). The distinction is one of level: governance decides who is responsible and how performance is monitored, whereas the process chapters describe what is done at each step.
| Neighbouring concept | How it differs |
|---|---|
| Medication reconciliation (SİY12) | A process at transitions of care; governance only appears when an organisation assigns, resources and monitors it (Fernandes et al., 2020). |
| Pharmacovigilance (SİY09) | Focuses on detecting and reporting adverse reactions; governance determines who is responsible for doing so (Sağlık Bakanlığı, 2020). |
| Safety culture | A property of the work unit; governance is the formal structure that can foster or ignore it (Vogus & Sutcliffe, 2007). |
| Formulary management (SİY02) | One of the tasks of the governance body, not the body itself (Matlala et al., 2017). |
5. Types and classifications
Three types of governance arrangement appear in the corpus. Committee-based governance relies on pharmacy and therapeutics committees that set formulary and drug-use policy (Matlala et al., 2017). Programme-based governance bundles interventions, often around high-risk drugs and event reporting (Cohen et al., 2005), or around a defined patient group such as older adults (Vandenberg et al., 2020). Service-based governance delegates responsibility to pharmacist-led services: reconciliation at admission or discharge (Mekonnen et al., 2016), transitional care clinics (Layman et al., 2020) and feedback to prescribers (Parker et al., 2019).
6. Theoretical frameworks and models
The corpus draws on three frameworks. High reliability thinking underlies the concept of safety organizing, in which units continuously detect and correct small failures (Vogus & Sutcliffe, 2007). Implementation science, notably the Consolidated Framework for Implementation Research, is used to explain why programmes succeed in some sites and not in others (Kegler et al., 2022). The learning health system model frames sequential, data-driven roll-out of a programme across sites (Vandenberg et al., 2020). None of these frameworks is specific to medicines; the field borrows them from organisational science.
7. Themes and bibliometric profile
The governance literature is small and recent compared with process-level topics. Most records evaluate a pharmacist-led service, and outcomes are usually readmissions, discrepancies or healthcare use, not harm (McNab et al., 2018; Mekonnen et al., 2016). Economic evaluation is rare, although a modelling study suggests that pharmacist-led reconciliation at discharge could be cost saving (Najafzadeh et al., 2016). Figure 5 summarises the bibliometric profile.
Records per year 2026 (incomplete)
Most frequent journals
Most frequent countries
Most frequent author keywords: pharmaceutical care (35), medication reconciliation (29), patient safety (21), medication errors (20), medication safety (19), clinical pharmacy (18), pharmacists (12), transitions of care (10), medication error (9), prescribing (9).
8. The situation in Türkiye
No record in this sub-topic has an author address in Türkiye. Turkish practice is therefore defined by regulation, chiefly the SKS requirement for a medication management team (Sağlık Bakanlığı, 2020), and not by published evaluations. Whether the SKS team works as a committee, a programme or a service, and with what effect, is an open empirical question.
9. Debates and contradictions in the literature
Structure or culture? Accreditation standards emphasise a formal team with written duties (Sağlık Bakanlığı, 2020), whereas organisational research finds that what matters on the ward is safety organizing and trusted leadership (Vogus & Sutcliffe, 2007). The two views are complementary only if the formal team actively shapes unit culture.
Process outcomes or patient outcomes? Pharmacist-led reconciliation reliably finds and resolves discrepancies, but improvements in patient outcomes or workload are not consistently seen (McNab et al., 2018). A pragmatic trial reported fewer clinically important errors at discharge without a reduction in healthcare use (Jost et al., 2024), while large health-system reports describe falling readmissions (Miller et al., 2020). Study design largely explains the difference.
Single programme or many local variants? A scoping review found that the concept of pharmacist-led reconciliation and the activities included in it vary widely, which calls for standardisation (Fernandes et al., 2020); implementation studies argue that local adaptation is necessary for uptake (Kegler et al., 2022).
10. Measurement problems
Governance is hard to measure because it acts indirectly. Studies use proxies such as discrepancies, readmissions or reported errors. Reported errors are a weak outcome, since better reporting cultures produce more reports (Vogus & Sutcliffe, 2007). Process measures (for example, the presence of a committee) say little about functioning: committees in one national survey varied widely in their structure and activities (Matlala et al., 2017). Few studies separate the effect of the governance structure from that of the clinical service it delivers.
11. Research gaps and agenda
- Does the presence and composition of an SKS medication management team predict lower medication harm in Turkish hospitals? (no Turkish evaluation exists in the corpus)
- Which committee functions (formulary, audit, feedback) carry most of the effect? (Matlala et al., 2017)
- Do pharmacist-led services reduce harm, not only discrepancies, when tested in adequately powered trials? (Jost et al., 2024; McNab et al., 2018)
- How can safety organizing be measured and fostered by a formal governance body? (Vogus & Sutcliffe, 2007)
- What is the cost-effectiveness of governance structures in middle-income health systems? (Najafzadeh et al., 2016)
- Which implementation strategies sustain programme effects across sites? (Kegler et al., 2022)
12. Implications for practice today
For a hospital preparing for SKS assessment, the evidence suggests three practical steps. First, give the SİY01 team a clear mandate and data: internal event reports and a short list of high-risk medications are enough to start (Cohen et al., 2005). Second, place pharmacists where errors arise, at transitions of care and in feedback to prescribers (Mekonnen et al., 2016; Parker et al., 2019). Third, treat leadership behaviour on wards as part of governance, not as an extra (Vogus & Sutcliffe, 2007).
Summary
- Medication safety governance assigns accountability for the whole medication-use process.
- SKS SİY01 requires a medication management team with written responsibilities.
- Programmes focused on high-risk drugs and fed by event reports can reduce harm.
- Pharmacist-led services reliably find discrepancies; effects on patient outcomes are mixed.
- Unit-level safety organizing and leadership matter alongside formal structures.
- There is no Turkish evaluation of governance structures in the corpus.
Discussion questions
- Why can individual diligence not replace governance in medication safety?
- Compare committee-based, programme-based and service-based governance.
- Why are reported errors a problematic outcome for evaluating governance?
- Design a one-year plan for a new SİY01 team in a 300-bed hospital. What data would it collect first?
- How would you test whether your hospital’s medication management team improves patient outcomes?
- What can a nurse manager do to strengthen safety organizing on a ward?
Further reading
- (Cohen et al., 2005): a clear example of a hospital-wide, low-cost programme with measured harm reduction.
- (Vogus & Sutcliffe, 2007): shows why culture and leadership must be part of governance.
- (Mekonnen et al., 2016): the key meta-analysis on pharmacist-led reconciliation.
- (McNab et al., 2018): a critical counterweight on patient outcomes.
- (Matlala et al., 2017): describes what committees actually do in a public hospital system.
- (Kegler et al., 2022): introduces implementation science for medication safety programmes.
Glossary
| Turkish | English | Short definition |
|---|---|---|
| İlaç yönetimi ekibi | Medication management team | Team accountable for medication processes under SKS SİY01 |
| Eczane ve tedavi komitesi | Pharmacy and therapeutics committee | Multidisciplinary body for formulary and drug policy |
| Klinik eczacı | Clinical pharmacist | Pharmacist working on patient-level therapy |
| Güvenlik örgütlenmesi | Safety organizing | Collective error detection and correction on units |
| Uygulama bilimi | Implementation science | Study of how interventions are adopted and sustained |
References
Cohen, M. M., Kimmel, N. L., Benage, M. K., Cox, M. J., Sanders, N., Spence, D., & Chen, J. (2005). Medication safety program reduces adverse drug events in a community hospital. Quality & Safety in Health Care, 14(3), 169-174. https://doi.org/10.1136/qshc.2004.010942
Fernandes, B. D., Almeida, P. H. R. F., Foppa, A. A., Sousa, C. T., Ayres, L. R., & Chemello, C. (2020). Pharmacist-led medication reconciliation at patient discharge: A scoping review. Research in Social & Administrative Pharmacy, 16(5), 605-613. https://doi.org/10.1016/j.sapharm.2019.08.001
Jost, M., Kos, M. K., Kos, M., & Knez, L. (2024). Effectiveness of pharmacist-led medication reconciliation on medication errors at hospital discharge and healthcare utilization in the next 30 days: a pragmatic clinical trial. Frontiers in Pharmacology, 15, Article 1377781. https://doi.org/10.3389/fphar.2024.1377781
Kegler, M. C., Rana, S., Vandenberg, A. E., Hastings, S. N., Hwang, U., Eucker, S. A., & Vaughan, C. P. (2022). Use of the consolidated framework for implementation research in a mixed methods evaluation of the EQUIPPED medication safety program in four academic health system emergency departments. Frontiers in Health Services, 2, Article 1053489. https://doi.org/10.3389/frhs.2022.1053489
Layman, S. N., Elliott, W. V., Regen, S. M., & Keough, L. A. (2020). Implementation of a pharmacist-led transitional care clinic. American Journal of Health-System Pharmacy, 77(12), 966-971. https://doi.org/10.1093/ajhp/zxaa080
Matlala, M., Gous, A. G. S., Godman, B., & Meyer, J. C. (2017). Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications. Expert Review of Clinical Pharmacology, 10(11), 1273-1280. https://doi.org/10.1080/17512433.2017.1364625
McNab, D., Bowie, P., Ross, A., Macwalter, G., Ryan, M., & Morrison, J. (2018). Systematic review and meta-analysis of the effectiveness of pharmacist-led medication reconciliation in the community after hospital discharge. BMJ Quality & Safety, 27(4), 308-320. https://doi.org/10.1136/bmjqs-2017-007087
Mekonnen, A. B., McLachlan, A. J., & Brien, J. A. E. (2016). Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open, 6(2), Article e010003. https://doi.org/10.1136/bmjopen-2015-010003
Miller, D., Ramsey, M., L’Hommedieu, T. R., & Verbosky, L. (2020). Pharmacist-led transitions-of-care program reduces 30-day readmission rates for Medicare patients in a large health system. American Journal of Health-System Pharmacy, 77(12), 972-978. https://doi.org/10.1093/ajhp/zxaa071
Najafzadeh, M., Schnipper, J. L., Shrank, W. H., Kymes, S., Brennan, T. A., & Choudhry, N. K. (2016). Economic Value of Pharmacist-Led Medication Reconciliation for Reducing Medication Errors After Hospital Discharge. American Journal of Managed Care, 22(10), 654.
Parker, H., Farrell, O., Bethune, R., Hodgetts, A., & Mattick, K. (2019). Pharmacist-led, video-stimulated feedback to reduce prescribing errors in doctors-in-training: A mixed methods evaluation. British Journal of Clinical Pharmacology, 85(10), 2405-2413. https://doi.org/10.1111/bcp.14065
Reeder, C. E., Dickson, M., Kozma, C. M., & Santell, J. P. (1997). ASHP national survey of pharmacy practice in acute care settings – 1996. American Journal of Health-System Pharmacy, 54(6), 653-669. https://doi.org/10.1093/ajhp/54.6.653
Sağlık Bakanlığı. (2020). Sağlıkta kalite standartları: Hastane (Sürüm 6.1). Sağlık Hizmetleri Genel Müdürlüğü, Sağlıkta Kalite, Akreditasyon ve Çalışan Hakları Dairesi Başkanlığı. https://dosyamerkez.saglik.gov.tr/Eklenti/41258/0/skshastane-seti-s-61–09082021pdf.pdf
Vandenberg, A. E., Kegler, M., Hastings, S. N., Hwang, U., Wu, D., Stevens, M. B., Clevenger, C., Eucker, S., Genes, N., Huang, W. N., Ikpe-Ekpo, E., Nassisi, D., Previll, L., Rodriguez, S., Sanon, M., Schlientz, D., Vigliotti, D., & Vaughan, C. P. (2020). Sequential implementation of the EQUIPPED geriatric medication safety program as a learning health system. International Journal for Quality in Health Care, 32(7), 470-476. https://doi.org/10.1093/intqhc/mzaa077
Vogus, T. J., & Sutcliffe, K. M. (2007). The impact of safety organizing, trusted leadership, and care pathways on reported medication errors in hospital nursing units. Medical Care, 45(10), 997-1002. https://doi.org/10.1097/MLR.0b013e318053674f
Source verification and AI use statement
Source verification. All 15 references were generated programmatically from the Web of Science records of the corpus, so authors, year, title, journal and DOI match the records exactly; every in-text citation was cross-checked by code against the reference list. Claims were checked against the record abstracts; full texts were not read. The SKS Hospital Set (Version 6.1) is the only source outside the corpus; it was accessed and read for this chapter.
AI use statement. Claude (Anthropic) was used to merge and de-duplicate the Web of Science exports, assign records to sub-topics, compute the bibliometric indicators and figures, and draft the text under the author’s instructions. The author is responsible for the final content.
Data and supplementary material
Supplementary file S1 (Excel) lists the 138 records of this chapter (authors, year, title, journal, DOI, title match flag), together with the full screening log of the 4948-record corpus and the citation verification report. The list is not reproduced here; it is available from the author on request.